Regeneus lines up manufacturer for US CryoShot trial: Industry News: Australian Life Scientist http://t.co/zVuW85cSEd
— Derek Del Simone (@Recruit_Health) January 22, 2014
CryoShot
Canine is an allogenic cell therapy for treating osteoarthritis and
other musculoskeletal conditions in dogs. It is produced from adipose
tissue of a donor animal. Regeneus is currently working on a human
version of CryoShot using the same techniques. - See more at:
http://lifescientist.com.au/content/biotechnology/news/regeneus-lines-up-manufacturer-for-us-cryoshot-trial-1231691767#sthash.zRdRy6d1.dpuf
CryoShot
Canine is an allogenic cell therapy for treating osteoarthritis and
other musculoskeletal conditions in dogs. It is produced from adipose
tissue of a donor animal. Regeneus is currently working on a human
version of CryoShot using the same techniques. - See more at:
http://lifescientist.com.au/content/biotechnology/news/regeneus-lines-up-manufacturer-for-us-cryoshot-trial-1231691767#sthash.zRdRy6d1.dpuf
CryoShot Canine is an allogenic cell therapy for treating osteoarthritis and other musculoskeletal conditions in dogs. It is produced from adipose tissue of a donor animal. Regeneus is currently working on a human version of CryoShot using the same techniques. - See more at: http://lifescientist.com.au/content/biotechnology/news/regeneus-lines-up-manufacturer-for-us-cryoshot-trial-1231691767#sthash.zRdRy6d1.dpuf
Aucun commentaire:
Enregistrer un commentaire